Racial and Ethnic Disparities in Second Primary Lung Cancer After Breast Radiotherapy: A SEER Cohort Analysis
Fares A Qtaishat1, Mohammad Hamad1, Adham Musa2
1School of Medicine, University of Jordan, Amman 11942, Jordan.
Breast cancer radiation increases second lung cancer risk, varying by race and marital status. Married patients face lower risk and better survival, highlighting disparities in survivorship care.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- Adjuvant radiation therapy for breast cancer improves survival but poses a risk of second primary lung cancer (SPLC).
- Racial, ethnic, and social disparities in SPLC risk among breast cancer survivors are not well understood.
Purpose of the Study:
- To quantify racial and ethnic differences in SPLC incidence and survival.
- To investigate the role of marital status in SPLC risk and survival.
Main Methods:
- Utilized SEER-17 data (2000-2022) for breast cancer patients receiving radiotherapy.
- Calculated standardized incidence ratios (SIRs) for SPLC by race/ethnicity and marital status.
- Assessed five-year overall survival (OS) post-SPLC and mean age at death.
Main Results:
- SPLC risk varied significantly by race; American Indian/Alaska Native (AI/AN) patients had the highest risk (SIR 1.82).
- Black and Asian/Pacific Islander (API) survivors had sustained elevated SPLC risk, while White and Hispanic survivors had lower risk.
- Married individuals had 12% lower SPLC incidence (SIR 0.88) and improved OS (31.8% vs. 25.0%) compared to unmarried patients.
Conclusions:
- SPLC risk and outcomes after breast radiotherapy are influenced by race, ethnicity, and marital status.
- Findings underscore the need for tailored survivorship counseling and personalized lung cancer screening for breast cancer survivors.
- Addressing disparities in SPLC risk and survival is crucial for improving long-term outcomes.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Related Concept Videos
Cancer Survival Analysis
Statistical Methods for Analyzing Epidemiological Data
